SOAT1 and neoplasm: As discussed above, pharmacological inhibitors, such as JAK/STAT pathway blockers, can be used to dampen the undesirable antiviral response in tumor cells, thereby transiently suppressing type I IFN signaling and reducing the expression of antiviral ISGs.